Metraipolis › archive › dc_d4e490b55cc8

N-Benzylpyrrolidine Compounds with MAO-B Inhibitory Activity in an Experimental Model of Parkinson's Disease — Europe PMC PMID:41828713

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41828713
DOI
10.3390/ijms27052496
License (as archived)
solo-consultazione
Archived
2026-11-04T23:17:38.920Z
SHA-256 of the archived text
8f385607f3b7ec336e416d836af8dd8a584f87395852d0be8de3d0498059e70f
Stable URL of this page
https://metraipolis.com/documento/dc_d4e490b55cc8

How to cite

N-Benzylpyrrolidine Compounds with MAO-B Inhibitory Activity in an Experimental Model of Parkinson's Disease — Europe PMC PMID:41828713 — Europe PMC (en), https://europepmc.org/article/MED/41828713 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d4e490b55cc8 (Metraipolis archive dc_d4e490b55cc8, sha256 8f385607f3b7ec336e416d836af8dd8a584f87395852d0be8de3d0498059e70f)
BibTeX
@misc{dcd4e490b55cc8,
  title = {N-Benzylpyrrolidine Compounds with MAO-B Inhibitory Activity in an Experimental Model of Parkinson's Disease — Europe PMC PMID:41828713},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41828713},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d4e490b55cc8; sha256 8f385607f3b7ec336e416d836af8dd8a584f87395852d0be8de3d0498059e70f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41828713. Agents can read the archived copy with the MCP tool read_document.